Detalhe da pesquisa
1.
The management of myelofibrosis: A British Society for Haematology Guideline.
Br J Haematol
; 204(1): 136-150, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38037886
2.
Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline.
Br J Haematol
; 204(1): 127-135, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932932
3.
Outcome of COVID-19 in patients with chronic myeloid leukemia: A single centre UK experience.
J Med Virol
; 94(4): 1274-1276, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914847
4.
Immune thrombocytopenia flare with mild COVID-19 infection in pregnancy: A case report.
Br J Haematol
; 190(3): e146-e148, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32516503
5.
Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19).
Am J Hematol
; 95(7): 861-862, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32298486
6.
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial.
J Clin Oncol
; 41(19): 3534-3544, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37126762
7.
Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology guideline
Br. j. haematol
; 204(1): 127-134, 20240101.
Artigo
em Inglês
| BIGG | ID: biblio-1537641
8.
The management of myelofibrosis: a British Society for Haematology guideline
Br. j. haematol
; 204(1): 136-150, 20240101.
Artigo
em Inglês
| BIGG | ID: biblio-1537635
9.
Improvement in mortality of hospitalized patients with hematological malignancies in the 2nd wave of COVID-19 in the UK: experience of a large London NHS trust.
Leuk Lymphoma
; 63(1): 227-230, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34470547
10.
Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom.
Leuk Lymphoma
; 62(2): 469-472, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33167718
11.
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm.
Leukemia
; 35(8): 2424-2430, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580204